Organic Letters
Letter
a
Scheme 1. Solubilization Strategies for Poorly Soluble
Table 1. Reductive N-Alkylation of Peptide Hydrazides
b
HPLC purity (%)
entry
1
2
aldehyde
solvent
4
5a
2a
2a
2a
2a
2b
HFIP
HFIP
42
50
87
86
68
<1
2
6
<1
4
c
3
4
50% AcOH−HFIP
50% AcOH−HFIP
50% AcOH−HFIP
d
5
a
Reactions were performed as follows: The peptide hydrazide 1a (1
mM) and aldehyde 2 (1.5 mM) were dissolved in the solvent and
then incubated at 37 °C for 1 h. After the addition of pic-BH (20
3
equiv) to the mixture, the reduction was performed at 37 °C for 1 h.
After removal of the solvent by air blowing, the crude material was
washed with Et O. The resulting precipitate was dissolved in 20%
2
b
CH CN−H O and analyzed by HPLC. Detected at 220 nm.
Reduction was performed for 24 h. Reduction was performed for 10
3
2
c
d
min.
short reduction time (10 min) resulted in the suppression of
peptide amide formation (entry 4). Using 4-formylbenzamide
(
2b) bearing an electron-withdrawing group, lower reactivity
18
to the reduction of the hydrazone (entry 5) was observed. In
light of these results, 4-anisaldehyde was used in the
subsequent experiments.
peptide hydrazide by a selective reductive N-alkylation, (2)
assembly of peptide segments by ligation with the tag-installed
soluble peptide, and (3) Cu(II)-mediated selective oxidative
hydrolysis of the N-alkylated hydrazide to produce the
corresponding carboxylic acid with the temporarily introduced
solubilizing tags removed. In this Letter, we used C-terminal
peptide hydrazides to evaluate the applicability of this
hydrazide chemistry to the solubilization of poorly soluble
peptides.
We then examined the Cu-mediated oxidative hydrolysis of
the N-alkyl hydrazide. The crude material prepared by
reductive alkylation of the hydrazide (1a) with 4-anisaldehyde
reacted with CuSO ·5H O (20 equiv) in 20% CH CN-
containing aqueous solution, affording the corresponding
carboxylic acid (6a) in a full conversion within 1 h (Table 2,
entry 1). The hydrolysis also proceeded with decreased
4
2
3
amounts of CuSO (2.0 equiv) or even only catalytic amounts
4
In our initial attempts to complete the envisioned reactions,
of copper salt (0.1 equiv) under an oxygen atmosphere (entries
2 and 3). The benzyl alcohol (7) and 4-anisaldehyde (2a) were
observed simultaneously as coproducts during the hydrolysis.
The possible role of the Cu(II) salt would be as an oxidant to
form an acyl diazene intermediate from the N-alkyl hydrazide,
yielding a carboxylic acid and a diazene derivative (8) (Scheme
2). The diazene would afford benzyl alcohol and benzaldehyde
the peptide hydrazide Ac-LYRANA-NHNH (1a) was used as
2
1
4
a substrate, and 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP)
was selected as the solvent for the installation of the
solubilizing tag. HFIP has the ability to assist in dissolving
15
poorly soluble peptides in other solvents, which is necessary
because this strategy is to be applied to poorly soluble
compounds. The peptide hydrazide (1a) and 4-anisaldehyde
19
through further oxidation or tautomerization, respectively.
(
2a), which has an electron-donating group, were reacted in
The behavior of eight C-terminal amino acids (Ala, Val, Phe,
Ser, Thr, His, Lys, and Arg) was also evaluated. As summarized
in Table 2, the desired carboxylic acids (6a−6h) were obtained
with moderate to high purity (62−91%). The epimerization of
C-terminal amino acids (Ala and Val) was suppressed (epimer
ratio >99:1, Figure S19). The peptide consisting of oxidative-
HFIP for 1 h; then, 20 equiv of 2-picoline−borane complex
(
corresponding N-alkyl hydrazide (4aa) in 42% yield (Table 1
entry 1). The increase in the reaction time to 24 h for the
reduction slightly improved the conversion, but the reaction
was incomplete (entry 2). The use of AcOH as a cosolvent
with HFIP (50% (v/v)) accelerated the reductive alkylation
1
6
pic-BH ) was added to the reaction mixture, affording the
3
prone residues, H-WCLYRAM-NH , was stable under the Cu-
2
the disulfide dimer was immediately formed (Figure S20).
A synthetic application of our strategy was confirmed
through the synthesis of human immunodeficiency virus type 1
(HIV-1) protease, inhibitors of which have been used for the
1
7
(
entries 3−5). After the reduction for 1 h followed by
exposure to an air-stream and subsequent trituration with Et O
2
to remove the solvent and excess reagents, the N-alkylated
hydrazide was obtained in 87% yield together with a small
amount of the peptide amide (5a), which was probably
generated by reductive cleavage of the hydrazide moiety. A
20
treatment of acquired immunodeficiency syndrome. Total
chemical synthesis of this enzyme was reported by Kent et al.,
1
654
Org. Lett. 2021, 23, 1653−1658